China Medical System, a Chinese pharmaceutical company listed on the Singapore Exchange's main board, started trading on Tuesday (July 15), and its share price rose by more than 10%. It is listed on the SGX, marking the 40th stock in the healthc...
China Medical System, a Chinese pharmaceutical company listed on the Singapore Exchange's main board, started trading on Tuesday (July 15), and its share price rose by more than 10%.
It is listed on the SGX, marking the 40th stock in the healthcare industry in the local stock market.
Group expressed its hope to replicate the success achieved in the Chinese pharmaceutical industry in Southeast Asia with its mature operation experience in the Chinese market.
Kangzhe Pharmaceutical said last month that the second listing will help deepen its layout in Southeast Asia and "reach Singapore's new and mature investor base."
The stock opened at 2.05 yuan on Tuesday morning, and its share price rose to 2.18 yuan in less than half an hour, 6.3% higher than the opening price.
Kangzhe Pharmaceutical is a pharmaceutical company focusing on innovative drugs and focusing on the Chinese market. The company has been listed on the Hong Kong Stock Exchange since 2010.
As of around 11 o'clock, Kangzhe Pharmaceutical's stock price had reached 2.26 yuan, up 10.2% from the opening price, and once rose to 2.29 yuan. About 250,000 shares were transferred on Tuesday morning, with a total transaction amount of 550,000 yuan.
The statement also stated that this second listing does not involve the issuance of new shares. The company mainly continues to be listed and traded on the Hong Kong Stock Exchange.
